Synthetic lethality in cancer: mechanism exploration and therapeutic applications

Area of Science:

• Genetics
• Molecular Biology
• Cancer Therapeutics

Background:

• Synthetic lethality (SL) describes a genetic interaction where mutating either gene alone is viable, but simultaneous mutation is lethal.
• SL uncovers gene redundancy and complementarity, forming a basis for precision cancer therapies.
• This approach selectively eliminates cancer cells by exploiting pathways crucial for tumor-specific genetic defects.

Purpose of the Study:

• To review the molecular mechanisms of synthetic lethality in cancer.
• To summarize strategies for discovering synthetic lethality targets.
• To discuss clinical applications and future directions of synthetic lethality.

Main Methods:

• Review of core molecular mechanisms in DNA damage repair, cell cycle checkpoint regulation, metabolic reprogramming, and epigenetic regulation.
• Summary of target discovery strategies using high-throughput functional genomics and computational biology.
• Discussion of clinical translation cases, including poly(ADP-ribose) polymerase (PARP) inhibitors.

Main Results:

• Synthetic lethality mechanisms are diverse, involving DNA repair, cell cycle control, metabolism, and epigenetics.
• High-throughput functional genomics and computational biology are key for identifying SL targets.
• Poly(ADP-ribose) polymerase (PARP) inhibitors represent a successful clinical application of SL.

Conclusions:

• Synthetic lethality offers a powerful strategy for targeted cancer therapy.
• Further research into SL mechanisms and target discovery will expand its clinical utility.
• Overcoming current challenges is crucial for advancing SL-based cancer treatments.